Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer

• Chun-Wai Mai,
• Zuzana Macek Jilkova,
• Zuzana Macek Jilkova,
• Kamal Dua,
• Kamal Dua,
• Bey-Hing Goh,
• Bey-Hing Goh

Affiliations

Chun-Wai Mai

Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia

Zuzana Macek Jilkova

Univ. Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institute for Advanced Biosciences, Grenoble, France

Zuzana Macek Jilkova

Hepato-Gastroenterology and Digestive Oncology, Department, University Hospital Grenoble, Grenoble, France

Kamal Dua

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, Australia

Kamal Dua

Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia

Bey-Hing Goh

Sunway Biofunctional Molecules Discovery Centre, School of Medical and Life Sciences, Sunway University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia

Bey-Hing Goh

Biofunctional Molecule Exploratory Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia